NEWS & VIEWS

Global private equity and venture capital news and research

Posts Tagged ‘ARCH Venture Partners’

27 May 2014

Tao Invest leads Twist Bioscience’s $26m Series B

twist San Francisco-based synthetic DNA producer Twist Bioscience has secured $26m in a Series B round led by Tao Invest.

19 May 2014

Sorbent Therapeutics secures $6.5m

medical monitor Biopharmaceutical startup Sorbent Therapeutics, which is focused on developing therapies for cardiovascular and renal diseases, has closed a $6.5m tranche in its $15m Series D funding round.

24 April 2014

ARCH Ventures back in the market for $250m eighth fundp

Menz-Holz-rose-arch Veteran venture capital investor ARCH Venture Partners has launched its eighth fundraise with its eye on up to $250m of new capital, AltAssets can reveal.

13 March 2014

OrbiMed helps Sage Therapeutics raise $38m

medical monitor Healthcare-focused investment firm OrbiMed Advisors participated in a $38m Series C round for biopharmaceutical company Sage Therapeutics.

24 December 2013

Madison Dearborn nears $1.5bn Ikaria buyout from PE, venture firms

drug-pharma-medical-healthcare US buyout house Madison Dearborn Partners is reportedly nearing a $1.5bn-plus deal to buy private equity and venture capital-backed drug business Ikaria.

25 November 2013

BC Partners, Onex to bid for venture capital-backed Ikaria

biotech_lrg Private equity firms BC Partners, Onex Corp and American Securities are reportedly set to make second round bids for specialty drug business Ikaria.

16 October 2013

SAGE Therapeutics raises $20m from Arch Venture Partners, Third Rock

pharmaceutical 12_sq Arch Venture Partners and Third Rock Ventures have invested $20m in SAGE Therapeutics, bringing the biopharmaceutical company’s fundraising total to $57.8m.

12 April 2013

Syros raises $30m from ARCH Venture Partners and Flagship Ventures

Newly launched cancer treatment specialist Syros Pharmaceuticals has secured $30m in Series A funding for the development of its gene control medicines.

11 April 2013

Polaris Partners leads AgBiome’s $14.5m round

Boston-based private equity firm Polaris Partners has led a $14.5m Series A round for AgBiome, which develops agricultural products to improve crop productivity.


Legals & Terms of UsePrivacy Policy


AltAssets is registered as a trademark of Investor Networks Limited (06695690).
Registered Office: Zetland House, 5-25 Scrutton St, London EC2A 4HJ
Content is © AltAssets 2000-2014